Abstract:Background. A culture of stringent drug policy, one-size-fits-all treatment approaches, and drug-related stigma has clouded clinical HIV practice in the United States. The result is a series of missed opportunities in the HIV care environment. An approach which may address the broken relationship between patient and provider is harm reduction—which removes judgment and operates at the patient’s stage of readiness. Harm reduction is not a routine part of care; rather, it exists outside clinic walls, exacerbating the divide between compassionate, stigma-free services and the medical system. Methods. Qualitative, phenomenological, semi-structured, individual interviews with patients and providers were conducted in three publicly-funded clinics in Chicago, located in areas of high HIV prevalence and drug use and serving African-American patients ( N = 38). A deductive thematic analysis guided the process, including: the creation of an index code list, transcription and verification of interviews, manual coding, notation of emerging themes and refinement of code definitions, two more rounds of coding within AtlasTi, calculation of Cohen’s Kappa for interrater reliability, queries of major codes and analysis of additional common themes. Results. Thematic analysis of findings indicated that the majority of patients felt receptive to harm reduction interventions (safer injection counseling, safer stimulant use counseling, overdose prevention information, supply provision) from their provider, and expressed anticipated gratitude for harm reduction information and/or supplies within the HIV care visit, although some were reluctant to talk openly about their drug use. Provider results were mixed, with more receptivity reported by advanced practice nurses, and more barriers cited by physicians. Notable barriers included: role-perceptions, limited time, inadequate training, and the patients themselves. Discussion. Patients are willing to receive harm reduction interventions from their HIV care providers, while provider receptiveness is mixed. The findings reveal critical implications for diffusion of harm reduction into HIV care, including the need to address cited barriers for both patients and providers to ensure feasibility of implementation. Strategies to address these barriers are discussed, and recommendations for further research are also shared.

"We're Not Gonna Aid You in Shooting Up": Stigma's Relationship to Harm Reduction in People Who Inject Drugs

“I Know It Is Going to Ruin Their Life:” Fortune-Telling, Agency, and Harm Reduction in Narratives Concerning Injection Initiation Assistance

Harm reduction interventions in HIV care: a qualitative exploration of patient and provider perspectives

Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia

Community Support for Harm Reduction and Treatment of Opioid Use Disorder

Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan

“We Weren’t Raised that Way”: Using Stigma Management Communication Theory to Understand How Families Manage the Stigma of Substance Abuse

Prescribing Syringes to People Who Inject Drugs: Advancing Harm Reduction in Primary Care

Public support for harm reduction: A population survey of Canadian adults

Decreasing Stigma Toward People Who Inject Drugs: Harm Reduction Training for First-Year Medical Students

Experiences of stigma and subsequent reduced access to health care among women who inject drugs

Dealing with low access to harm reduction: a qualitative study of the strategies and risk environments of people who use drugs in a small Swedish city

A qualitative exploration of harm reduction in practice by street-based peer outreach workers

Stigma: how it affects the substance use disorder patient

How to be self-reliant in a stigmatising context? Challenges facing people who inject drugs in Vietnam

Women who use drugs: engagement in practices of harm reduction care

Meeting people where they are: implementing hospital-based substance use harm reduction

Acceptability and Effectiveness of Hepatitis C Care at Syringe Service Programs for People Who Inject Drugs in New York City

Financial barriers, facilitators, and strategies among syringe services programs in the U.S., and their impact on implementation and health outcomes

Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital

Solutions to Reduce the Social Harms of Stigma